RedHill Biopharma announces U.S. commercialization agreement for FDA-approved GI product esomeprazole strontium delayed-release capsules

18th August 2017 Uncategorised 0

B3C newswire

More: RedHill Biopharma announces U.S. commercialization agreement for FDA-approved GI product esomeprazole strontium delayed-release capsules
Source: MDlinx